October 15, 2024 (Globalinvestorideas.com Newswire) Globalinvestorideas.com, a go-to platform for big investing ideas for active stock traders reports on today’s top volume leaders on the NASDAQ.
AI stock Zapata Computing Holdings Inc. (NASDAQ: ZPTA) leads the pack, trading at 0.1242, up 0.0472, gaining 61.2192% on volume of over 544 million shares as of this report.
According to Tip Ranks two days ago – “In a regulatory filing, Zapata AI disclosed that on October 7, the board of the company approved the termination of all of the company’s employees, except for a small number of employees to be retained for a short period to administer termination of business activities, including Sumit Kapur, the company’s CFO. All such employees were terminated effective October 9. Such actions took place in connection with a planned cessation of the company’s operations. The company cannot currently estimate the charges it will incur under generally accepted accounting principles as a result of the termination of its employees.
AI leader NVIDIA Corporation (NASDAQ:NVDA) also makes the top five volume leaders as of this report, trading down for the day. The stock is trading at $130.99, down $7.08, losing 5.13% on volume of over 306 Million shares. The stock pulled back as other semiconductor shares fell, leaving investors to ask if this is a buying opportunity.
Other top trades include Gritstone bio, Inc. (NASDAQ:GRTS).The stock is trading at 0.0718, gaining 0.0178, up 32.9630% on volume of over 339 Million shares as of this report.
This stock is also in trouble with TipRanks reporting “Gritstone bio, Inc., a biotech firm specializing in potent vaccines, has voluntarily filed for Chapter 11 bankruptcy to restructure and preserve its value while continuing operations. This move is part of a strategic process to explore alternatives and secure a stalking horse bidder to maximize value, demonstrating commitment to advancing clinical programs. Despite the filing, the company aims to maintain normal operations and minimize impact on stakeholders, continuing its mission to develop innovative immunotherapies and vaccines for oncology and infectious diseases.”
Disclaimer
Global Investor Ideas is part of the Investorideas.com content umbrella and is owned by Econ Corporate Services Inc. For Investorideas disclosure and disclaimer please visit the site directly
Disclaimer/Disclosure: GlobalInvestorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by GlobalInvestorideas and investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. If we are not the source for content but just a publisher , please contact the source of all content for questions and info. We are not responsible for third party content.